Prerna Launches CANTEL: India's First MicroRNA Based Blood Test for Breast Cancer Screening
Oct 16, 2025
Hyderabad (Telangana) [India], October 16: PrecisionRNA Biotech Pvt. Ltd. (Prerna), a leading healthcare innovation company from Hyderabad, today announced the launch of Cantelâ„¢, India's first microRNA-based blood test for breast cancer screening. This groundbreaking test is set to transform early detection by offering a simple, convenient, and highly accurate alternative to traditional methods, addressing the critical screening gap that has led to late-stage diagnosis of breast cancer in India.